ChiCTR-OCS-13003773
正在进行
/
/
/
2013-11-11
/
/
Valvular Heart Disease
亞洲心臟瓣膜病前瞻性登記冊
亞洲心臟瓣膜病前瞻性登記冊
亞洲心臟瓣膜病前瞻性登記冊
单臂
其它
NA
/
Division of Cardiology, Department of Medicine and Therapeutics
/
300
/
2013-11-06
1990-01-01
/
a) Patients with significant MR or AS (≥mild); b) Patients with organic MR or AS; c) Patients able to undergo a comprehensive echocardiographic evaluation; d) The patient or the guardian gives written informed consent before participating the study; e) The patient is willing to give full information on his/her medical history, including the drugs.；
登录查看a) Patient with functional (for example, ischemic MR) MR; b) Patient with concomitant valvular heart disease other than MR or AS; c) Patient with other concomitant congenital heart disease.；
登录查看NO
/
谱新生物Hillgene2025-10-21
药研网2025-10-21
求实药社2025-10-21
求实药社2025-10-21
求实药社2025-10-21
佰傲谷BioValley2025-10-21
醴泽资本 LYZZCapital2025-10-21
信立泰药业2025-10-21
康威生物2025-10-21
数字医疗2025-10-21
400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
友情链接: 摩熵医药 摩熵医药企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科 中国医疗人才网 医药招商网
